March 6, 2013 | Chronic inflammatory bowel disease is on the rise in industrialized countries. At the Institute of Clinical Molecular Biology in Kiel, Germany, physicians and scientists are working hand in hand to identify the impact of genetic variants on pathology through next-generation sequencing.
